CORCEPT THERAPEUTICS INC (CORT) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
CORCEPT THERAPEUTICS INC (CORT) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$153.80 MLiabilities$182.93 MNon-current liabilities$29.12 MCurrent assets$439.68 MEquity$705.78 MGross equity(calculated)$1.70 BAssets$888.70 MNon-current assets$449.03 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSShort-term marketable securitiesCash and cash equivalentsTrade receivables, net of allowancesPrepaid expenses and other current assetsInventoryLong-term marketable securitiesDeferred tax assets, netStrategic inventoryOperating lease right-of-use assetProperty and equipment, netOther assetsAccrued and other liabilitiesAccrued research and development expensesAccounts payableShort-term operating lease liabilityLong-term accrued income taxesLong-term operating lease liabilityLong-term accrued government rebatesAdditional paid-in capitalRetained earningsAccumulated other comprehensive incomeCommon stockCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Treasury stockAccrued and other liabilitiesAccrued and other liabilities$115.35 MCurrent liabilitiesCurrent liabilities$153.80 MAccrued research and development expensesAccrued research and development expenses$21.63 MLiabilitiesLiabilities$182.93 MAccounts payableAccounts payable$14.91 MShort-term operating lease liabilityShort-term operating lease liability$1.92 MLong-term accrued income taxesLong-term accrued income taxes$15.49 MNon-current liabilitiesNon-current liabilities$29.12 MCurrent assetsCurrent assets$439.68 MShort-term marketable securitiesShort-term marketable securities$197.16 MLong-term operating lease liabilityLong-term operating lease liability$7.50 MEquityEquity$705.78 MLong-term accrued government rebatesLong-term accrued government rebates$6.13 MCash and cash equivalentsCash and cash equivalents$111.04 MGross equity (calculated)Gross equity(calculated)$1.70 BAssetsAssets$888.70 MTrade receivables, net of allowancesTrade receivables, net of allowances$76.92 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$41.37 MInventoryInventory$13.19 MAdditional paid-in capitalAdditional paid-in capital$1.05 BLong-term marketable securitiesLong-term marketable securities$236.45 MNon-current assetsNon-current assets$449.03 MDeferred tax assets, netDeferred tax assets, net$178.68 MStrategic inventoryStrategic inventory$18.96 MOperating lease right-of-use assetOperating lease right-of-use asset$6.86 MProperty and equipment, netProperty and equipment, net$5.13 MOther assetsOther assets$2.95 MRetained earningsRetained earnings$654.61 MAccumulated other comprehensive incomeAccumulated other comprehensive income$436.00 KCommon stockCommon stock$142.00 KTreasury stockTreasury stock−$998.01 M
Chart details

CORCEPT THERAPEUTICS INC (CORT) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
888,702,000 US dollars
Current assets
439,676,000 US dollars
Non-current assets
449,026,000 US dollars
Liabilities
182,926,000 US dollars
Current liabilities
153,802,000 US dollars
Non-current liabilities
29,124,000 US dollars
Equity
705,776,000 US dollars
Short-term marketable securities
197,158,000 US dollars
Cash and cash equivalents
111,039,000 US dollars
Trade receivables, net of allowances
76,920,000 US dollars
Prepaid expenses and other current assets
41,374,000 US dollars
Inventory
13,185,000 US dollars
Long-term marketable securities
236,451,000 US dollars
Deferred tax assets, net
178,680,000 US dollars
Strategic inventory
18,956,000 US dollars
Operating lease right-of-use asset
6,860,000 US dollars
Property and equipment, net
5,133,000 US dollars
Other assets
2,946,000 US dollars
Accrued and other liabilities
115,347,000 US dollars
Accrued research and development expenses
21,628,000 US dollars
Accounts payable
14,910,000 US dollars
Short-term operating lease liability
1,917,000 US dollars
Long-term accrued income taxes
15,488,000 US dollars
Long-term operating lease liability
7,504,000 US dollars
Long-term accrued government rebates
6,132,000 US dollars
Additional paid-in capital
1,048,598,000 US dollars
Retained earnings
654,613,000 US dollars
Accumulated other comprehensive income
436,000 US dollars
Common stock
142,000 US dollars
Preferred stock
0 US dollars
Treasury stock
negative 998,013,000 US dollars
Gross equity (calculated)
1,703,789,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
CORCEPT THERAPEUTICS INC (CORT) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!